Aurora Spine Corporation (ASG.V)
| Previous Close | 0.2800 |
| Open | 0.2650 |
| Bid | 0.2800 x 0 |
| Ask | 0.2950 x 0 |
| Day's Range | 0.2650 - 0.2800 |
| 52 Week Range | 0.2300 - 0.4650 |
| Volume | |
| Avg. Volume | 14,406 |
| Market Cap | 21.678M |
| Beta (5Y Monthly) | 0.64 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.0400 |
| Earnings Date | May 13, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
Simply Wall St.Aurora Spine Full Year 2023 Earnings: US$0.02 loss per share (vs US$0.022 loss in FY 2022)
Aurora Spine ( CVE:ASG ) Full Year 2023 Results Key Financial Results Revenue: US$14.5m (down 2.4% from FY 2022). Net...
GlobeNewswireAurora Spine Corporation Announces Fourth Quarter and Fiscal 2023 Financial Results
NOT FOR DISTRIBUTION IN THE UNITED STATES OR OVER UNITED STATES WIRE SERVICES CARLSBAD, Calif., April 29, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a leader in spine and interventional spine technology that improves spinal surgery outcomes, today announced its financial results for fiscal 2023 ended December 31, 2023. The company experienced strong, successive, quarter over quarter revenue growth, while overcoming early year o
- GlobeNewswire
Aurora Spine Corporation Celebrates Second Anniversary of Initial Implantation of the World’s First Bone Density Matched DEXA-C Cervical Interbody Fusion Device
CARLSBAD, Calif., March 20, 2024 (GLOBE NEWSWIRE) -- Aurora Spine Corporation (“Aurora Spine” or the “Company”) (TSXV: ASG) (OTCQB: ASAPF), a manufacturer of innovative spinal implants announced today that it has completed the second full year of implantation of the world’s first patient-bone-density matched interbody device, the cervical interbody DEXA-C. Trent Northcutt, CEO and President at Aurora Spine said, "It's a significant milestone for Aurora to celebrate the second anniversary of the
